Singular Genomics Systems Stock Market Value
OMIC Stock | USD 0.41 0.01 2.50% |
Symbol | Singular |
Singular Genomics Systems Price To Book Ratio
Is Singular Genomics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.30) | Revenue Per Share 0.04 | Quarterly Revenue Growth 0.413 | Return On Assets (0.21) | Return On Equity (0.43) |
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Singular Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Singular Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Singular Genomics.
04/02/2024 |
| 05/02/2024 |
If you would invest 0.00 in Singular Genomics on April 2, 2024 and sell it all today you would earn a total of 0.00 from holding Singular Genomics Systems or generate 0.0% return on investment in Singular Genomics over 30 days. Singular Genomics is related to or competes with InfuSystems Holdings, Pro Dex, LeMaitre Vascular, Utah Medical, Milestone Scientific, AngioDynamics, and ATRION. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics t... More
Singular Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Singular Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Singular Genomics Systems upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.05) | |||
Maximum Drawdown | 23.39 | |||
Value At Risk | (8.70) | |||
Potential Upside | 8.51 |
Singular Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Singular Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Singular Genomics' standard deviation. In reality, there are many statistical measures that can use Singular Genomics historical prices to predict the future Singular Genomics' volatility.Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.22) | |||
Total Risk Alpha | (0.54) | |||
Treynor Ratio | (0.23) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Singular Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Singular Genomics Systems Backtested Returns
Singular Genomics Systems owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0807, which indicates the firm had a -0.0807% return per unit of risk over the last 3 months. Singular Genomics Systems exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Singular Genomics' Coefficient Of Variation of (2,842), risk adjusted performance of (0.01), and Variance of 25.14 to confirm the risk estimate we provide. The entity has a beta of 0.81, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Singular Genomics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Singular Genomics is expected to be smaller as well. Singular Genomics Systems has an expected return of -0.41%. Please make sure to validate Singular Genomics value at risk and the relationship between the kurtosis and market facilitation index , to decide if Singular Genomics Systems performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.27 |
Weak reverse predictability
Singular Genomics Systems has weak reverse predictability. Overlapping area represents the amount of predictability between Singular Genomics time series from 2nd of April 2024 to 17th of April 2024 and 17th of April 2024 to 2nd of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Singular Genomics Systems price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Singular Genomics price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.27 | |
Spearman Rank Test | -0.66 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Singular Genomics Systems lagged returns against current returns
Autocorrelation, which is Singular Genomics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Singular Genomics' stock expected returns. We can calculate the autocorrelation of Singular Genomics returns to help us make a trade decision. For example, suppose you find that Singular Genomics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Singular Genomics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Singular Genomics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Singular Genomics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Singular Genomics stock over time.
Current vs Lagged Prices |
Timeline |
Singular Genomics Lagged Returns
When evaluating Singular Genomics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Singular Genomics stock have on its future price. Singular Genomics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Singular Genomics autocorrelation shows the relationship between Singular Genomics stock current value and its past values and can show if there is a momentum factor associated with investing in Singular Genomics Systems.
Regressed Prices |
Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Singular Genomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Singular Genomics' short interest history, or implied volatility extrapolated from Singular Genomics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Singular Genomics Correlation, Singular Genomics Volatility and Singular Genomics Alpha and Beta module to complement your research on Singular Genomics. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Singular Stock analysis
When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Singular Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.